Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
New FMD vaccine developed in USA
Licensing for use expected soon

Researchers in the US Department of Homeland Security's Plum Island Animal Disease Center have developed a new vaccine for Foot-and-Mouth Disease (FMD). It is hoped that the new vaccine will offer longer-lasting immunity to the disease than is provided by the existing vaccine and will prove safer to manufacture, leading to a reduction in the expenditure and inconvenience involved in both the manufacturing process and the current need to vaccinate 3-4 times per year.

Also of note is the inclusion of an antibody test which will allow veterinary surgeons to determined vaccinated animals from infected animals, because present testing for FMD erroneously returns a positive result for both. The ability to achieve more accurate results will likely have beneficial effects upon trade, as a better understanding of the state of the spread of the disease will likely allow greater confidence amongst importers.

Commenting, Research Leader of the Centre's Foreign Animal Disease Research Unit Dr Luis Rodriquez said “It's a very good innovation - the most effective way to date and very promising technology. I think it's going to revolutionise the way we look at FMD vaccines around the world today.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.